By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ARYx Therapeutics, Inc. 

2255 Martin Avenue, Suite F

Santa Clara  California  95050  U.S.A.
Phone: 408-869-2761 Fax: 408-869-2773



Company News
ARYx Therapeutics, Inc. Informed of Additional Delay by FDA and Begins Wind-Down of Operations 3/10/2011 7:13:58 AM
ARYx Therapeutics, Inc. Clarifies Current Status of Operations 12/27/2010 6:49:23 AM
ARYx Therapeutics, Inc. to Transfer to the NASDAQ Capital Market 12/21/2010 9:23:53 AM
ARYx Therapeutics, Inc. Fails to Obtain Financing; Company Restructures and Terminates All Current Employees and Officers 12/15/2010 6:19:24 PM
ARYx Therapeutics, Inc. Receives NASDAQ Notice of Non-Compliance 10/11/2010 12:47:12 PM
ARYx Therapeutics, Inc. Secures Interim Financing of $6.3 Million; Should Allow ARYx To Operate Through End of 2010 8/16/2010 6:49:05 AM
ARYx Therapeutics, Inc. Announces Resignation of Peter G. Milner, President Research and Development 6/3/2010 10:37:40 AM
ARYx Therapeutics, Inc. Reports First Quarter 2010 Results of Operations 5/13/2010 8:51:13 AM
ARYx Therapeutics, Inc. Schedules First Quarter 2010 Results Conference Call 5/5/2010 9:27:33 AM
ARYx Therapeutics, Inc. Reports Fourth Quarter and Full Year 2009 Results of Operations 3/29/2010 9:15:57 AM